The Long-Term Care Data Cooperative is a National Institute on Aging-funded resource that links nursing home health records with Medicare and Medicaid claims for dementia research. In 2026, adult children can ask how that research affects a parent's daily care, drug safety, and consent. The Cooperative is a provider-led effort. It brings together records from many nursing homes to study which treatments work, prepare for public-health needs, and recruit homes and residents into large Phase 3 and 4 trials that take place during usual care.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the Cooperative does with nursing home records
- Why dementia research looked different in 2026
- What risky drug use means for a parent with dementia
- Which questions to ask at the care meeting
What the Cooperative does with nursing home records
The Cooperative compiles electronic health records across many long-term-care companies. According to the National Institute on Aging in its fiscal year 2026 budget materials, the effort includes over 2,500 nursing facilities from more than 150 companies representing more than 2 million residents NIA budget overview. Those records are linked with Medicare and Medicaid claims. According to the U.S.
National Library of Medicine summary of the May 2026 validation paper, that link supports comparative-effectiveness and interventional research in skilled-nursing facilities validation study summary. For families, this means routine notes can become research data. Vitals, stays, glucose readings, and drug orders help researchers compare outcomes across homes. A May 2026 check of 2023 residents found 45.5 percent had dementia, close to the national figure of 47.2 percent.
Why dementia research looked different in 2026
NIA held a virtual Dementia Care and Caregiving Research Summit on March 17-19, 2026. It reviewed progress and unmet needs to guide Alzheimer's and related-dementias milestones and planning. That timing matters because nursing-home trials now run inside daily care. The Cooperative was built to improve treatment outcomes, support preparedness, and help providers and residents join embedded pragmatic trials.
The trial does not happen in a separate lab. It happens where a parent eats, sleeps, and receives drugs. Ask whether a home takes part. Ask what data leaves the chart and who protects it.
What risky drug use means for a parent with dementia
Sedating and brain-altering drugs carry special risks for people with dementia. According to Medical Xpress reporting on the UCLA JAMA study from January 2026, about 1 in 4 traditional Medicare beneficiaries with dementia received potentially inappropriate brain-altering drugs linked to falls, confusion, and hospitalization report on the UCLA study. Antipsychotics carry the strongest FDA boxed warning for elderly patients with dementia-related psychosis because of higher death risk.
The pooled FDA analysis showed about 4.5 percent deaths on drug versus 2.6 percent on placebo over 10 weeks. The warning does not ban all use. It means the reason, dose, duration, and monitoring need a clear plan. Families can ask for that plan in plain terms at each visit.
Which questions to ask at the care meeting
Bring the drug list and ask for a reason tied to diagnosis. Ask what non-drug steps were tried first, such as pain checks, sleep routines, daytime activity, hearing aids, or a quieter room.
Write down the answers and review date. If confusion, falls, or excess sleepiness appear after a new order, call the nurse and prescriber promptly and ask whether the drug could be the cause.
- What is the exact diagnosis and symptom this sedating drug treats?
- What non-drug options were tried, and what helped?
- What benefit should we see, what side effects should we watch, and when is the next review?
- What is the stop date or taper plan if it does not help?
- Does this home share records with the Cooperative or join embedded trials, and what consent does that involve for my parent?
You Might Also Like
- Electronic Health Records for Dementia Care Research in 2026: Questions Adult Children Can Ask About the Research
- The Long-Term Care Data Cooperative and Dementia Research in 2026: Study Design and Evidence Limits for Adult Children
- Serious Illness and End-of-Life Dementia Research Priorities in 2026: Questions Adult Children Can Ask Local Care Programs
